In 2019, the medical evaluation market for marijuana was valued at $ 1.2 trillion. However, with the fight against COVID-19, its value increased by 14.1% so far in 2020.
The increase in tests for medicinal purposes led to the legalization of marijuana in several countries. According to Globe Newswire, more than 30 nations have legalized the use of Cannabis for medical treatment.
Meanwhile, in the United States, there are 25 states that have legalized the use of medical Cannabis. Four of them also did it with the recreational one. They are Colorado, Washington, Oregon and Alaska.
The use of marijuana for the fight against COVID-19
As the fight against COVID-19 continues, the market for medical Cannabis is expected to increase further and further.
According to Globe Newswire, the University of Miami has studied the impact of quarantine on marijuana use.
Additionally, the University of Lethbridge in Alberta, Canada, along with other researchers, worked with Cannabis extracts. The interest is to prevent infection of SARS-CoV-2, which is the virus that causes COVID-19.
These are the main laboratories that are conducting experiments
The main laboratories that work with them are Agilent Technologies, Waters, Shimadzu, PerkinElmer and Millipore Sigma, among others.
Also noteworthy, so far in 2020, the market entry of Sensabues AB, in conjunction with RCU Labs, and the Israeli firm Stero Therapeutics.
In India, since 2019, AYUSH works with the use of Cannabis for the management of pain in terminal diseases.
However, the portal acknowledges that it will take several more months for it to become an effective option against the disease.
Until this Thursday, worldwide the death toll from COVID-19 exceeded 625 thousand, with more than 15.3 million confirmed cases. Of these, more than 8.7 million recoveries are reported.